Amanote Research

Amanote Research

    RegisterSign In

When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

Journal of Mammary Gland Biology and Neoplasia - United States
doi 10.1007/s10911-011-9206-4
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

April 6, 2011

Authors
Amy ChowCarlos L. ArteagaShizhen Emily Wang
Publisher

Springer Science and Business Media LLC


Related search

AMPK: A Contextual Oncogene or Tumor Suppressor?

Cancer Research
Cancer ResearchOncology
2013English

SIRT3: Oncogene and Tumor Suppressor in Cancer

Cancers
Cancer ResearchOncology
2017English

GPRC5A: A Potential Tumor Suppressor and Oncogene

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

DYRK1A in Down Syndrome: An Oncogene or Tumor Suppressor?

Journal of Clinical Investigation
Medicine
2012English

Tumor Suppressor Role of miR-3622b-5p in ERBB2-positive Cancer

Oncotarget
Oncology
2017English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

The Mysterious Ways of ErbB2/HER2 Trafficking

Membranes
Process ChemistryFiltrationChemical EngineeringSeparationTechnology
2014English

TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor

Genes
Genetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy